Forty-three percent of corporate CFO respondents said the failure to effectively integrate two organizations following the close of a transaction is their primary worry. Henry Ristuccia, a partner at Deloitte, said integration worries board members, CFOs and other executives alike because “cultural integration remains more unpredictable, and therefore a riskier proposition.”
Here are the six top concerns for CFOs following a successful deal, according to the Deloitte survey.
• Failure to effectively integrate: 43 percent
• Changing regulatory and legislative environment: 16 percent
• Inaccurate target valuation: 14 percent
• Economic uncertainty: 12 percent
• Insufficient due diligence process: 8 percent
• Improper target identification: 4 percent
Deloitte’s M&A survey was based on responses from about 200 corporate directors and CFOs from public companies with annual revenue of $500 million or more.
More Articles on Hospital and Health System CFOs:
CFO Compensation of the 25 Top-Grossing Nonprofit Hospitals
HealthEast Care System Names Doug Davenport CFO
Healthcare CFO Lessons: The Overhaul of a Consumer Printer Company
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
